SAGE Therapeutics Inc (SAGE.OQ)
SAGE.OQ on NASDAQ Stock Exchange Global Market
101.99USD
14 Dec 2018
101.99USD
14 Dec 2018
Change (% chg)
$1.37 (+1.36%)
$1.37 (+1.36%)
Prev Close
$100.62
$100.62
Open
$100.00
$100.00
Day's High
$106.69
$106.69
Day's Low
$99.56
$99.56
Volume
197,677
197,677
Avg. Vol
131,861
131,861
52-wk High
$195.97
$195.97
52-wk Low
$99.56
$99.56
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- ownership
- filings
- deals
- private equity
- third-party document and information retrieval
- estimates
- fundamentals
- economics
- events
- news
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
| Name | Age | Since | Current Position |
|---|---|---|---|
Kevin Starr |
55 | 2016 | Independent Chairman of the Board |
Jeffrey Jonas |
65 | 2013 | President, Chief Executive Officer, Director |
Kimi Iguchi |
55 | 2016 | Chief Financial Officer, Treasurer |
Anne Cook |
56 | 2017 | Senior Vice President, General Counsel, Secretary |
Albert Robichaud |
57 | 2011 | Chief Scientific Officer |